The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric Cancer
Official Title: An Open-label, Non-randomized Phase II Trial of Cetuximab in Combination With Irinotecan and 5-FU/FA for Patients With Metastatic Gastric Cancer
Study ID: NCT01123811
Brief Summary: Based on the current promising results with irinotecan and cetuximab in patients with recurrent metastatic colorectal cancer, and the excellent results of Irinotecan and 5-FU in gastric cancer , the present clinical study to evaluate the overall response rate, the time to progression and the overall survival of the combined treatment of cetuximab and irinotecan and 5-FU in patients with esophagogastric cancer is urgently needed.
Detailed Description: Cetuximab will be analysed with biological markers
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Städtische Kliniken Esslingen, Esslingen, Baden-Württemberg, Germany
Klinikum Ludwigsburg, Medizinische Klinik I, Ludwigsburg, Baden-Württemberg, Germany
Universitätsklinikum Ulm, Abt. Innere Medizin I, Ulm, Baden-Württemberg, Germany
Klinikum rechts der Isar der technischen Universität München, III. Medizinische Klinik: Hämatologie / Onkologie, München, Bayern, Germany
Medizinische Hochschule Hannover, Abteilung Gastroenterologie, Hepatologie und Endokrinologie, Hannover, Niedersachsen, Germany
Universitätsklinkum Essen, Innere Klinik und Poliklinik - Tumorforschung, Essen, Nordrhein-Westfalen, Germany
Kliniken Essen-Mitte / Evang. Huyssens-Stiftung, Klinik für Innere Medizin I und Internistische Onkologie / Hämatologie, Essen, Nordrhein-Westfalen, Germany
Prosper-Hospital Recklinghausen, Medizinische Klinik I, Recklinghausen, Nordrhein-Westfalen, Germany
Klinikum der Johannes Gutenberg-Universität, I. Medizinische Klinik u. Poliklinik, Mainz, Rheinland-Pfalz, Germany
Charité - Campus Benjamin Franklin, Medizinische Klinik I, Berlin, , Germany
Name: M Moehler, Md Ph D
Affiliation: Johannes Gutenberg Univetsity
Role: PRINCIPAL_INVESTIGATOR